The Wasdell Group, an outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialization service ahead of the EU FMD and U.S. DSCSA implementation deadlines. Following a £2.8 million investment into serialization capabilities in 2016, the company will offer compliant products to all markets, including Europe and the U.S., from its sites in Newcastle and Swindon. Wasdell’s new facility in Ireland, due to open Janua...